Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
65.71M | 97.98M | 82.28M | 64.95M | 51.75M | Gross Profit |
24.64M | 47.45M | 40.99M | 30.15M | 20.17M | EBIT |
4.79M | 24.42M | 28.80M | 20.22M | 10.18M | EBITDA |
20.63M | 43.09M | 39.84M | 30.09M | 19.03M | Net Income Common Stockholders |
8.48M | 26.32M | 25.26M | 20.58M | 13.03M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
123.97M | 134.67M | 160.94M | 80.32M | 55.80M | Total Assets |
158.66M | 170.82M | 214.73M | 107.62M | 80.29M | Total Debt |
8.40M | 12.52M | 13.90M | 1.86M | 3.84M | Net Debt |
-103.09M | -114.71M | -141.33M | -71.86M | -41.96M | Total Liabilities |
25.39M | 45.94M | 71.04M | 24.77M | 22.30M | Stockholders Equity |
129.50M | 121.96M | 140.12M | 82.85M | 57.99M |
Cash Flow | Free Cash Flow | |||
-2.51M | 23.43M | 49.18M | 22.76M | 9.17M | Operating Cash Flow |
6.30M | 32.80M | 62.33M | 29.57M | 18.17M | Investing Cash Flow |
-11.10M | -8.48M | -14.14M | -2.20M | -19.28M | Financing Cash Flow |
-6.57M | -45.69M | 30.65M | -1.67M | -1.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | HK$1.15B | 15.50 | 12.85% | ― | 957.74% | 194.12% | |
61 Neutral | HK$198.37M | 39.20 | 3.96% | ― | -14.39% | -69.66% | |
59 Neutral | $10.74B | 10.21 | -6.69% | 3.04% | 7.44% | -10.92% | |
41 Neutral | €19.67M | ― | -27.10% | ― | -6.25% | 84.71% | |
37 Underperform | HK$29.75M | ― | ― | -16.98% | 62.42% |